We are thrilled to announce there are only 8 days left to invest in our campaign. Don’t miss out on the last chance to invest in Epilog’s current funding round! 

Three massive markets for AI Vision:

• Auto Industry: The vision systems developed by Epilog are intended for use in self-driving cars. SideCar, a device for retrofitting existing cars, can tap into a car's existing computer, to allow several functions associated with self-driving technology.

• Healthcare: Initial company revenues are anticipated to stem from Wellcome, a comprehensive, non-contact, non-invasive digital health-check device. It can measure body temperature, perspiration, blood oxygenation, along with height and weight

• Queue Management: The vision technology has applications in improving efficient traffic flow on public roads, airports, theme parks, and more.

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

The video below demonstrates a 400 Megapixel digital zoom into microscopic worlds. We believe Epilog's approach is novel in that it makes possible viewing an entire sample, and every microscopic detail simultaneously and in real-time. When combined with Epilog’s advanced AI capability, we expect to be able to build intelligent microscopes with unprecedented power.

The development of this technology was motivated by our recent foray into health diagnostics (Wellcome). Conceptually the capability is similar to our vision systems for big spaces and large distances but the implementation details are different, and we intend for it to be separately patented.  We see many future potential applications of this technology for new product development in medical diagnostics and other applications.

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

This video demonstrates the last step of the autonomy pipeline - motion planning and control. In motion planning, the goal is to control the ego vehicle to reach the desired destination in a safe, comfortable, legal, and efficient manner.

In traditional approaches, motion planning is decomposed into the sub-problems of route behavior and trajectory planning. The goal of route planning is to find an optimum route from the current location of the self-driving vehicle to the destination location.  In the simplest case, the objective is to find the shortest path from A to B, however, different actors can lead to complex transitions as each driving situation needs to be explicitly handled and some scenarios can yield unexpected outcomes.

Using a driving corridor that specifies free space regions that the self-driving vehicle should drive within usually defined by how obstacles should be passed or which vehicles the self-driving vehicle should follow or stay ahead of can improve driving behavior. Regardless, since the velocity and direction profiles are optimized separately this can lead to suboptimal behavior.

Enter deep learning-based planning, which basically sidesteps the traditional algorithm-based navigation. Using deep learning the full trajectory representation where the path and the velocity can be simultaneously optimized using vision.  This approach not only leads to natural driving decisions but also leads to behaviors that can be achieved by the subsequent trajectory planning.

The below video is the visualization of the SideCar AI, the left side is what the AI sees from the front of the car and the right side is the top-down view of the road. The AI outputs the car's future position (in green) and is fully end-to-end so it can predict where to drive in all situations including traffic lights and stop signs using deep learning algorithms.

San Jose, CA – November 18, 2021  -   Epilog Imaging systems, Inc. a developer of super-resolution AI vision systems for self-driving cars and autonomous queue management, announced today that Mr. Kelly J. Stopher has joined the Company as its Chief Financial Officer.

With over 30 years experience in accounting and finance, Mr. Stopher’s career includes management and executive positions as Chief Financial Officer for Lee Read Jewelers, Inc. (Boise, ID),  Chief Financial Officer for Weldon Barber (Spokane, WA), Account Executive for Aston Group (Vancouver, BC),  Business Relationship Manager for Wells Fargo (Spokane, WA) ,  CFO/Director for Jayhawk Energy, Inc. (Coeur d’Alene, ID) and CFO for Zenlabs Holdings, Inc. (Vancouver, BC). 

Mr. Stopher is expected to work for Epilog on a part-time basis. Mr. Stopher presently also occupies the position of Chief Financial Officer, Secretary & Treasurer of Star Gold Corp., and President of National Silver and Lead Mining.   Mr. Stopher is Managing Partner at Palouse Advisory Partners LLC, a firm specializing in accounting and financial consulting for pre-IPO and publicly traded companies. 

Mr. Stopher received an undergraduate degree from Washington State University and began his career with Langlow Tolles, PS (Tacoma, WA) where he passed all sections of the Certified Public Accountant examination.  

linkedin.com/in/kelly-j-stopher-9346a4a

Below you will find our recent regulatory filing with the U.S. Securities & Exchange Commission (SEC) establishing our target closing date of December 17, 2021 for our Regulation A+ offering under the current terms.  Over 2,164 people have invested in Epilog this round and we are looking forward to a good portion of the near 10,000 followers of this campaign to also join us.  Thank you for being part of our journey!

253G2 1 epilog_253g2.htm 253G2

Filed pursuant to Rule 253(g)(2)

File No. 024-11331

SUPPLEMENT DATED NOVEMBER 8, 2021

 TO THE OFFERING CIRCULAR DATED MARCH 19, 2021

 OF EPILOG IMAGING SYSTEMS, INC.

This document supplements, and should be read in conjunction with, the Offering Circular (the “Offering Circular”) dated March 19, 2021 of Epilog Imagine Systems, Inc. (the “Company”). Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circular.

 The purpose of this supplement is to

• Announce the Company’s intention to terminate the offering described in the Offering Circular such that the last day on which subscriptions will be accepted is December 17, 2021, as qualified by reference to the description of the Company’s intentions below.

Offering Termination Date 

The Company intends to terminate the offering for its Common Stock described in the Offering Circular. No further subscriptions will be accepted for the current offering after December 17, 2021 (the “Termination Date”). Subscriptions in the offering will be accepted up through that date and processed as promptly as possible. None of the terms of the offering have been changed. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion. 

We just crossed the $2M mark in our campaign and added over 2,000 investors in Epilog!  On behalf of team Epilog, we welcome all our new investors as well as all the existing ones that have been steadily increasing their position in Epilog.  We are most grateful for the kind, gracious, and continued support from everyone in the StarteEngine community!

If you are one of the almost 10,000 followers of our campaign and did not invest yet this round, it is not too late.

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

Here is a demonstration of SideCar's Driver Monitoring System (DMS). SideCar DMS technology is used to make sure the driver is paying attention to the road ahead at all times, in particular while SideCar is activated. SideCar driver monitoring AI is end-to-end, meaning the AI directly measures the driver distraction level, shown as a percentage confidence level.   Unlike the typical “keep-hands-on-the-wheel” approach commonly used by most manufacturers, the advanced SideCAR DMS is tamper-proof, helping deliver our top priority of occupant safety. Additionally, to ensure occupant privacy, videos captured in-cabin never leave SideCar unless the user has explicitly opted into data sharing to help improve SideCar. 

This video is not simulated.  The avatar is Computer Generated Imagery for illustration purposes.

Epilog started its Reg A+ campaign about six months ago, and it has become necessary to update the campaign page at this point to reflect all the exciting progress since the start.  Most noteworthy is the launch of a new subsidiary, Aperis LLC,  to differentiate our queue management offerings, now accepting pre-orders on aperis.ai.  Our main website  epilog.com is now being revised to reflect the organizational changes, a new exclusive investor area will also be added.  The new site is expected to be online in the December 2021 time frame. Next, the SideCar website will be further focused on Self-Driving technology. SideCar reservations are continuing to be accepted on drivesidecar.com.

In July 2021 Epilog formed a new wholly-owned subsidiary, Aperis to differentiate the branding/messaging for Epilog’s queue management products.  The name “Aperis” originates from the Latin root “Aperio” which literally means “Uncover” or “Reveal”.  Aperis products use Epilog’s highly advanced Artificial Intelligence and multispectral stereo imaging capabilities to gain new insights into the world around us.  Effective September 24, 2021, the  Aperis website is available online and accepting pre-orders: http://www.aperis.ai

Self-driving simulation provides a valuable tool for extending Sidecar test cases rapidly. 

The simulation tools we currently use incorporate a physics engine with detailed models of each vehicle’s subsystems. 

The simulation can be easily customized to different makes and models. 

The models enable simulating the unique kinematic properties of each vehicle. 

Different types of roads and traffic conditions can be simulated much faster and more systematically within a modeling environment, improving test coverage. 

For example, testing in bad weather conditions and fog is best first tested within a simulation environment. 

Because SideCar AI treats actual and simulated environments similarly, simulations can be reliably extended to reality in most cases. 

Highly detailed simulations, blur the line between models and reality, helping improve Sidecar by increasing the number and complexity of test cases more rapidly.

“My passion always was computers, really. I started at a very early age. I'm driven by challenges and when I realized how far away technology is from our ability to see, that was a problem that I wanted to help solve.” 

“We were making cameras in our garage that were [other than satellite cameras] the highest resolution in the world.”

“Where Epilog stands to differentiate is a convergence between that level of super-resolution with the emergence of artificial intelligence to solve the problems of machine vision.”

“Artificial intelligence is becoming more and more important in everything that we do, and it's finding its way into almost everything that you use, every instrument you use, every piece of software that you use.“

“The most exciting part of my job is probably bringing the opportunity for everyone to have a self-driving car.”

“Folks who are running businesses and have been impacted by the pandemic and need a way to protect our employees and their patrons are looking for the solution that WellCome has”. 

“In the future, I see people using Epilog technology in ways that we could never have imagined to make the world a safer, more efficient place.”

Thank you for being part of Epilog’s journey on StartEngine!  

We design and develop our products in Silicon Valley and manufacture them in the USA.  Our products infuse leading-edge optics with artificial intelligence. Combining these two fields, we are working to recreate human vision, a daunting and previously considered impossible task for many more decades. 

Our technology seamlessly integrates optics, electronics, and software in an optimum way to produce what we believe is unprecedented machine vision performance. We are currently showcasing our technology in two exciting new products. SideCar is a self-driving system designed to upgrade millions of vehicles on the road today to full autonomy. WellCome is a non-contact screening device designed to analyze and assess people’s health in real-time using AI vision.  

Thank you for sharing this journey with us.

WellCome is a comprehensive no-contact solution for health and safety screening in the medical environment. Upon entry, every individual’s health vitals are scanned and analyzed with Epilog AI technology. WellCome measures multiple health vitals in real-time, including body temperature, heart rate, blood oxygen level, and perspiration. If WellCome finds one of the health vitals is outside acceptable parameters, then a further health screening will be activated by a no-contact QR code questionnaire. Your healthcare team will use this information to make an informed decision to keep your office safe.  We believe WellCome is the most advanced and accurate health screening device for medical offices and facilities around the world.  To learn more and to order your device visit: aperis.ai

On July 12, 2021 Epilog formed a new wholly-owned subsidiary, “Aperis, LLC,” a California company. Aperis was established to differentiate the branding/messaging for Epilog’s queue management products, distinguishing it from the self-driving technology i.e. SideCar.  The name “Aperis” originates from the latin root “Aperio” which literally means “Uncover” or “Reveal”.  Aperis products use Epilog’s highly advanced Artificial Intelligence and multispectral stereo imaging capabilities to gain new insights into the world around us. The initial products being offered under the Aperis name are “Wellcome™” and “Closeview™”.   Wellcome is a vision-based health monitoring device designed for hypodermic AI metrics on humans from up to 10’ away.  Closeview is an 8K+ vision system designed to monitor indoor or outdoor spaces, extracting (revealing) details up to 500’ away along with people and vehicular motion flow analytics and perimeter protection. Additional information and ordering information will be available on the website aperis.ai shortly.

We are pleased to report that on August 3, 2021 the trademark SIDECAR has been allowed by the United States Patent and Trademark Office (USPTO.) The allowance is an International Class 9 authorization for a “Day and night vision system primarily comprising motion sensors and a camera for assisting drivers of vehicles.”  Epilog’s self-driving product was previously called “Sherpa” and the name change to Sidecar was motivated because of potential trademark conflicts.

A trademarked name helps protect a company’s products and services against infringement, and counterfeiting.  The Sidecar trademark provides protection for both Epilog and consumers alike and is an integral part of delivering quality products and services.

Wellcome is a non-contact health assessment device designed to help with screening potentially infected individuals from distances up to 10 feet away. Wellcome estimates health condition through accurate measurements of a person’s body temperature, blood oxygen level, heart rate as well as purely AI-based metrics including height, weight, age, and gender.

Wellcome is currently being offered for testing in medical offices under an evaluation program. The initial units will help fine-tune system performance and reliability as well as demonstrate each use case. A video captured at each demo location will be available for promotional and personnel training purposes.

Wellcome shares much of its core technology with other Epilog AI vision products and is expected to be available for pre-orders on the Aperis website in 3Q21.

Keeping track of people and vehicles flowing in and out of facilities is a difficult and tedious task for humans, both in private and public settings. Examples include looking after frequently visited, ignored or restricted zones, idle vehicles and/or persons, perimeter breaches, safety and/or liability concerns. AI-generated real-time insights can provide actionable intelligence for facility managers, reducing response times and the chance for errors.

Leveraging the Epilog patented AI vision technology platform, CloseView is a new concept currently being developed under Aperis branding to address the huge challenge of AI coverage of large spaces. CloseView is designed to significantly reduce system complexity/cost, simplify installation, reduce scene illumination requirements and eliminate the reliability issues associated with “robotic” systems. Parking lots are the primary target market for CloseView as illustrated in the attached visualization. The US has as many as two billion* parking spots, an estimated 20% of accidents (50,000†) and 500,000+ violent crimes‡ that occur in parking lots each year.  Many government facilities and/or complexes can receive additional benefits from CloseView through pending infrastructure upgrades.

More details on CloseView will be announced in the months ahead, first samples are expected to be ready in Q4 time frame.

* According to Bloomberg  

†According to the National Safety Council   

‡ According to the U.S. Department of Justice

Dear investors, please claim your free T-shirt if you have not already! You qualified for a free T-shirt with a minimum total investment exceeding $500.  You should have received an email from support@epilog.com following your investment, containing a promo code with ordering instructions. Sometimes emails with web links get stuck in Spam filters so please check your mailboxes. You can also gift the T-shirt if you don’t need one; just forward the email to a friend, and they can claim it just the same. One T-shirt per promo code.  https://shop.epilog.com/

Epilog has formed a new wholly-owned subsidiary, “Aperis, LLC,” a California company. Aperis was established to differentiate the branding/messaging for our queue management products, distinguishing it from the self-driving technology (e.g. SideCar). Aperis will have its own dedicated website, trademarks, salesforce, distribution channels, and patent portfolio. The first product being offered under the Aperis brand is a remote health diagnostic device using the trademark “WellCome™” (formerly Tempo). The second product being developed under the Aperis brand uses the trademark “CloseView™”. The primary application for CloseView is AI analysis of the movement of people and vehicles in very large outdoor or indoor environments, e.g. warehouses, parking lots, etc. 

The best news is Epilog investors effectively now own two companies, Epilog and Aperis, each with a separate potential exit opportunity.  The logos presented below are concepts and are still being finalized.

The majority of driver assistance systems available on the road today use a collection of low-quality cell-phone type cameras to form their forward vision system. For example, our understanding is the Autopilot system "tiles" eight cameras, five looking forward and three looking rearwards. In comparison, Epilog Sidecar uses one 8K (25MP) vision system which we estimate to be 10x the image quality of the five Autopilot forward-looking cameras combined. By avoiding duplication and ambiguity inherent in tiled systems, we estimate SideCar can detect objects on the road with about 10x more precision and 3x farther away. Even better, to enjoy the benefits of Epilog technology you don’t need to buy a new car, just add a SideCar!

Epilog just surpassed the $1M fundraising mark in it’s Reg A+ offering. We have 1000+ new investors in just two months,  $2M+ raised in total and 3500+ shareholders. We wanted to thank every single one of our new investors that made this milestone possible. Together we are working to bring SideCar, Tempo, and at least one more exciting product to market this year. We want to congratulate all our shareholders in this success and thank them for sharing this journey.   

Here is a time lapse demonstration of Epilog SideCar driving on the coast of Northern California for about 20 minutes. We plan to make SideCar available for beta testing in Q3, starting with investors who have compatible cars. We’re also training the system on recognition of stop signs and traffic lights, lane changes, and navigation. Stay tuned!

The wait is finally over and you can now order Epilog T-shirts! Tell the world you are the proud owner of one of the coolest startups around!  If you already qualified as an investor you will get a promo code emailed to you.  If you did not make the minimum investment or you are just a fan, you can still purchase a T-shirt.  The T-shirts come in several colors and sizes and we plan to add more items to the store over time.  Please visit shop.epilog.com

It's our pleasure to announce that Epilog has crossed the $800K fundraising mark in just over a month since starting the Reg A+ offering. It is a tremendous show of momentum and commitment from the early investing community. We are thankful to every one of our over 3000 Epilog investors and excited to share our journey and success with you.

About a year ago we began developing a vision-based fever detection system in response to the pandemic. After careful competitor analysis, we are excited to present Tempo with two pending patents. Tempo is a standalone solution that can evaluate a person’s health from up to 15 feet away, by accurate assessments of body temperature, blood oxygen level, heart rate, height, weight, gender, and age. Combined with a contactless electronic survey, the system can help increase safety levels through screening of potentially infected persons before entering a business, school, or any other public place. Tempo is in production now, priced around $1,500, and expected to be available for sale in 2Q21.

DISCLAIMER This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment

Since the Tesla Autopilot is currently the leader in driver assistance systems we felt a direct comparison would be beneficial. Our understanding is Autopilot uses eight cameras for their vision system, five forward facing (most important) and three rear facing. Epilog Sidecar uses one 8K vision system which we estimate to be 10x the image quality of the five Autopilot cameras combined. To take that logic further, we estimate Sidecar can detect objects on the road with about 10x more detail and 3x farther away. Even better, to enjoy the benefits of Epilog technology you don’t need to buy a new car, just add a SideCar!

SideCar vs. Autopilot

DISCLAIMER This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment

We are happy to announce that Epilog crossed the half million dollar fundraising mark in about 3 weeks! We appreciate the amazing support from over 550 contributing investors, helping us ‘change-the-game’ in self-driving an advanced vision. The new funding well accelerate the technology development and help get our products to market much faster.

Michael Mojaver, CEO Epilog

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

We would like to express our gratitude for the amazing support we have received from the StartEngine community and the StartEngine team during our Testing The Waters Campaign with over $135K in reservations made in just over a week!!!   

If you were planning to invest, now is the best opportunity as our early-bird bonuses expire shortly. 

Join us in building the future of AI vision technology!

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.